Novel approaches for targeting muscle wasting in COPD

M. Steiner (Leicester (Leicestershire), United Kingdom)

Source: International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Steiner (Leicester (Leicestershire), United Kingdom). Novel approaches for targeting muscle wasting in COPD. International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of different methods to screen skeletal muscle function in chronic wasting diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 22s
Year: 2001

The relevance of respiratory muscle dysfunction and novel treatment options in COPD
Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies
Year: 2017


Unbiased analysis of skeletal muscle molecular responses upon pulmonary rehabilitation in advanced COPD
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018



Skeletal muscle inflammatory markers in COPD patients with muscle wasting
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


Novel diagnostic tools and interventions for COPD locomotor and respiratory muscle dysfunction 
Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies
Year: 2017


Permeabilized skeletal muscle fiber technique: a tool to unravel energy metabolism dysfunction in myopathy during chronic lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 393s
Year: 2003

Role of exosomal microRNA in driving skeletal muscle wasting in COPD
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015


Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

The association of vitamine D deficiency and skeletal muscle dysfunction in COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015

Ultrasound assessment of quadriceps muscle in COPD patients: Functional and clinical implications
Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases
Year: 2016

Impaired myogenesis in the quadriceps muscle of cachectic COPD patients
Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function
Year: 2014


New modalities of nutritional aspects of pulmonary disease in the elderly
Source: Eur Respir Mon; 2009: 43: 240–255
Year: 2009

Investigating circulating microRNAs as potential biomarkers of quadriceps weakness in COPD
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011

Evaluation of anti-aging klotho protein in COPD rehabilitation
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016

The effect of COPD on muscle structure and function
Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles
Year: 2006


Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006